The global neurovascular thrombectomy market is expected to reach a high CAGR of 8.0% over the Forecast Period 2025-2032., reaching USD XX million in 2024 and USD YY million in 2032. North America currently dominates the market due to its high incidence of acute ischaemic stroke, well-established healthcare infrastructure, and favourable reimbursement policies. The rising prevalence of acute ischaemic stroke, technological developments in thrombectomy devices, and increased knowledge of the benefits of mechanical thrombectomy operations all contribute to market expansion. However, the high cost of thrombectomy devices and procedures may limit market growth to some degree.
Growing Incidence of Acute Ischaemic Stroke Worldwide
Acute ischaemic stroke is among the top causes of death and disability worldwide. According to the World Stroke Organisation, 13.7 million new strokes occur each year, with around 80 million stroke survivors worldwide today. The rising incidence of acute ischaemic stroke, caused by factors such as an ageing population, unhealthy lifestyles, and an increase in cardiovascular disease prevalence, is predicted to boost demand for neurovascular thrombectomy devices and treatments.
Technological Advancements in Thrombectomy Devices
Thrombectomy devices have undergone significant technological developments in recent years to improve procedural safety and efficacy. For example, stent retrievers with larger diameters, longer lengths, and improved trackability have been created to allow for faster and more thorough revascularisation. Similarly, aspiration catheters with bigger inner diameters and flexible distal tips have been developed to improve clot clearance. According to research published in the Journal of Neurointerventional Surgery in 2021, new-generation thrombectomy devices produced effective reperfusion in 84.6% of first-pass cases, compared to 75.4% for earlier devices.
High cost of thromboectomy devices and procedures
Neurovascular thrombectomy devices are often expensive, ranging from $1,500 to $10,000 per unit, depending on the design and features. Furthermore, mechanical thrombectomy is a complicated process that necessitates large resources and properly educated healthcare staff. which raises the expense. The high cost of thrombectomy devices and procedures may limit their use, especially in cost-sensitive countries, as well as market growth to some extent.
Stent Retriever Segment to Dominate the Product Category
The stent retrievers segment dominated the neurovascular thrombectomy devices market in 2023. Stent retrievers are catheter-based devices that entrap and remove clots from blocked arteries. They have established the gold standard for mechanical thrombectomy due to their high recanalisation rates and favourable clinical outcomes. Stryker introduced the Surpass Evolve Flow Diverter System for treating brain aneurysms in the United States in January 2022. The device includes a delivery method that is intended to improve placement precision while retaining the device's porosity, allowing for consistent healing.
The aspiration catheter segment is predicted to increase at the fastest CAGR throughout the forecast period. Aspiration catheters are becoming more popular as first-line clot retrieval therapy, either alone or in combination with stent retrievers. They use continuous suction to aspirate the clot into the catheter. Penumbra got FDA approval for its RED 72 Reperfusion Catheter for aspiration thrombectomy in February 2022. The catheter has superior tracking technology and a wide inner diameter of 0.072 inches, allowing for fast and effective clot removal.
North America to Dominate the Global Neurovascular Thrombectomy Market
North America accounted for the highest share of the global neurovascular thrombectomy market in 2022. The region's high incidence of acute ischaemic stroke, well-established healthcare infrastructure, favourable reimbursement rules, and the presence of significant market participants all contribute to its large market share. According to the CDC, someone in the United States experiences a stroke every 40 seconds, with stroke-related costs totalling approximately $53 billion per year.
The CMS increased the reimbursement rate for mechanical thrombectomy operations conducted in hospital outpatient departments from about $9,000 to $16,000 beginning January 1, 2022. This should increase ischaemic stroke sufferers' access to treatment. The American Stroke Association also issued amended guidelines in 2022, recommending mechanical thrombectomy for eligible patients up to 24 hours after stroke onset, thereby expanding the treatment window.
The global neurovascular thrombectomy devices market is highly competitive and reasonably consolidated, with a few big companies controlling a sizable market share. These companies are concentrating on growing their product portfolios, geographical reach, and client base through strategic alliances, mergers and acquisitions, and new product launches.
Stryker Corporation had the greatest market share in 2022, trailing only Medtronic plc, Johnson & Johnson (Cerenovus), and Penumbra, Inc. Stryker provides a wide range of neurovascular thrombectomy products, including the Trevo stent retriever and the AXS Vecta 71 aspiration catheter. Stryker bought Surpass Medical Ltd., an Israeli business that manufactures the Surpass Streamline flow diverter device, in June 2021.
Medtronic plc's primary neurovascular thrombectomy products include the Solitaire stent retriever and the React aspiration catheter. Medtronic announced the acquisition of Intersect ENT in September 2021, expanding its product portfolio to include ear, nose, and throat. Other major market developments include Johnson & Johnson (Cerenovus) launching the EmboTrap III revascularisation device in January 2022 and Penumbra receiving FDA permission for ZOOM aspiration tubing in February 2022.
The global prevalence of acute ischaemic stroke and technological improvements in thrombectomy devices are driving growth in the neurovascular thrombectomy devices market. The COVID-19 pandemic had a negative influence on the market in 2020 because it delayed elective surgeries and disrupted the supply chain. However, the market is likely to recover strongly beginning in 2021 as the situation returns to normal.
Stent retrievers will continue to dominate the market in the future years, with aspiration catheters experiencing the most rapid increase. North America will remain the largest market, while the Asia-Pacific region is predicted to develop the most throughout the projection period due to increased awareness of stroke therapy, improved healthcare infrastructure, and rising disposable income in countries such as China and India.
The trend towards robotic-assisted treatments, as well as the development of neuroprotective drugs to reduce brain injury during mechanical thrombectomy procedures, are projected to fuel market innovation.
Stryker Corporation
Medtronic plc
Johnson & Johnson (Cerenovus)
Penumbra, Inc.
Terumo Corporation
Acandis GmbH
Phenox GmbH
Imperative Care, Inc.
Anaconda Biomed
In January 2022, Stryker introduced the Surpass Evolve Flow Diverter System in the United States.
In September 2021, Medtronic announced the acquisition of Intersect ENT
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope and Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking: Key Players
3.3. Market Share Analysis: Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies List by Country) (Premium)*
5. COMPANY PROFILES
5.1. Stryker Corporation
5.2. Medtronic plc
5.3. Johnson & Johnson (Cerenovus)
5.4. Penumbra, Inc.
5.5. Terumo Corporation
5.6. Acandis GmbH
5.7. Phenox GmbH
5.8. Imperative Care, Inc.
5.9. Anaconda Biomed
5.10. *LIST NOT EXHAUSTIVE
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Growing Incidence of Acute Ischaemic Stroke Worldwide
6.1.2. Technological Advancements in Thrombectomy Devices
6.1.3. Trend 3
6.2. Market Drivers
6.2.1. Rising Incidence of Acute Ischaemic Stroke
6.2.2. Technological Advancements in Thrombectomy Devices
6.2.3. Increasing Awareness about Benefits of Mechanical Thrombectomy
6.3. Market Restraints
6.3.1. High Cost of Thrombectomy Devices and Procedures
6.3.2. Limited Availability of Skilled Professionals
6.3.3. Unfavourable reimbursement scenario in some regions
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY PRODUCT (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (% (2025-2032)
7.1. Stent Retrievers
7.1.1. Solitaire
7.1.2. TREVO
7.1.3. EmboTrap
7.1.4. Others
7.2. Aspiration Catheters
7.2.1. ACE
7.2.2. Penumbra System
7.2.3. React
7.2.4. Others
7.3. Microcatheters & Microguidewires
7.3.1. Rebar
7.3.2. Synchro
7.3.3. Others
8. BY END USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (% (2025-2032)
8.1. Hospitals
8.2. Speciality Clinics
8.3. Ambulatory Surgical Centres
9. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (% (2025-2032)*
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. U.K.
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.3. Asia-Pacific
9.3.1. Japan
9.3.2. China
9.3.3. India
9.3.4. Australia
9.3.5. South Korea
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Argentina
9.5. Middle East & Africa
9.5.1. South Africa
9.5.2. Saudi Arabia
9.5.3. UAE
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (% (2025-2032)
By Product:
Stent Retriever
Aspiration Catheter
Microcatheters & Microguidewire
By End User:
Hospitals
Speciality Clinics
Ambulatory Surgical Centres
By Region:
North Americ
Europ
Asia-Pacifi
Latin Americ
Middle East & Afric
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511